Life Tech Details Real-Time Single-Molecule Tech at AGBT; Combines Qdots with FRET-Based Detection
March 02, 2010
Life Tech Details Real-Time Single-Molecule Tech at AGBT; Combines Qdots with FRET-Based Detection
So far, the company has only used the technology, internally named "Starlight," to sequence synthetic DNA of about 100 bases on approximately a dozen prototype machines, but early-access collaborations with research groups are slated to start in the fourth quarter.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- IOM Workshop Discusses Interim Strategies to Handle Unresolved Challenges of Clinical Sequencing
July 27, 2011 / Clinical Sequencing News - Life Tech Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance
March 22, 2011 / Clinical Sequencing News - USPTO Board Rules on PacBio, Life Tech Patent Interference Case
February 1, 2011 / In Sequence - In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence